STAT Plus: Battleground narrowed in CRISPR patent case between University of California and Broad
The contours of the latest battle over patents on the CRISPR genome editing technology are becoming a little clearer: In a decision released Monday evening, the U.S. patent office told the Broad Institute, on one side, and the University of California and its allies, on the other, what they’ll be allowed to fight about.
And in tennis terms, it’s advantage, Broad.
Continue to STAT Plus to read the full story…
